Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank63
3Y CAGR-15.5%
5Y CAGR-15.0%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-15.5%/yr
Annual compound
5Y CAGR
-15.0%/yr
Consistent
Percentile
P63
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $2.00M | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $297000.00 | -91.1% |
| 2021 | $3.32M | +44.6% |
| 2020 | $2.30M | -49.1% |
| 2019 | $4.51M | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |